ASHLEY LIESE: Open Payments
NPI 1427546894 · SMITHFIELD, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 79 payments from 18 companies in 2025. Trend: 2023 $2,471 · 2024 $1,948 · 2025 $1,593
Food & beverage: $1,593
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $378 |
| AstraZeneca Pharmaceuticals LP | 13 | $287 |
| ABBVIE INC. | 14 | $221 |
| Novo Nordisk Inc | 10 | $204 |
| Actelion Pharmaceuticals US, Inc. | 2 | $60 |
| Lilly USA, LLC | 2 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $49 |
| Verona Pharma, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 3 | $47 |
Products named: ELIQUIS, Rybelsus, NURTEC ODT, UBRELVY, BREZTRI, FARXIGA, AIRSUPRA, VRAYLAR.
Industry payments across RI — which companies pay providers there.
